National Guidelines for the Diagnosis, Treatment and Prevention of Malaria in Kenya

The country's malaria endemicity map, as depicted in Figure 1, indicates that malaria is prevalent in most areas, with the exception of the high-altitude regions of the Rift Valley and the coastal areas. According to epidemiological data, malaria is responsible for a substantial proportion of outpatient visits and hospital admissions, particularly among children under the age of five and pregnant women. The clinical features of malaria are characterized by fever, chills, and flu-like symptoms, which can progress to severe manifestations such as coma, seizures, and respiratory distress. Uncomplicated malaria is typically diagnosed based on clinical symptoms and confirmed by microscopy or rapid diagnostic tests. Severe malaria, on the other hand, requires prompt recognition and treatment to prevent mortality. The management of uncomplicated malaria involves the administration of artemether-lumefantrine, dihydroartimisinin-piperaquine, or other antimalarial medications, as outlined in Tables 1 and 2. The dosing schedule for these medications is critical to ensure effective treatment and prevent resistance. Treatment failure is a significant concern, and patients who do not respond to initial treatment should be referred to higher-level facilities for further evaluation and management. In contrast, severe malaria requires immediate recognition and treatment, including supportive care such as fluid resuscitation, oxygen therapy, and management of complications such as coma and seizures. The clinical parameters and laboratory findings that indicate severe malaria are outlined in Tables 3 and 4. Supportive treatment for manifestations of severe malaria is provided in Table 6. Malaria in pregnancy is a significant concern, particularly in areas with high malaria transmission. Pregnant women are more susceptible to severe malaria, and the disease can have devastating consequences for both the mother and the fetus. The management of uncomplicated malaria in pregnancy involves the administration of antimalarial medications, as outlined in Table 7. Severe malaria in pregnancy requires prompt recognition and treatment, including supportive care and management of complications. The prevention of malaria is a critical component of malaria control. Chemoprophylaxis for non-immune populations, vector control, and epidemic preparedness and response are essential strategies for preventing malaria. The use of insecticide-treated bed nets, indoor residual spraying, and larval control measures can significantly reduce malaria transmission. Advocacy, communication, and social mobilization are also critical for promoting malaria prevention and control measures. The pharmacology of antimalarials is outlined in Annex 2, and additional information on antimalarials is provided in Annex 3. The use of antimalarials requires careful consideration of the potential benefits and risks, including the risk of adverse reactions and resistance. The management of malaria medicines involves the use of essential drugs, quantification of antimalarial medicines, and rational use of anti-malarial medicines, as outlined in Chapter 8. In conclusion, malaria is a significant public health concern in Kenya, and effective management and prevention strategies are critical to reducing the burden of the disease. The National Malaria Control Program has developed guidelines for the diagnosis, treatment, and prevention of malaria in Kenya, which provide a framework for healthcare providers to manage malaria effectively.